01/02/2023 Stemnovate and Babraham Institute come together to untangle the tauopathy in Alzheimer’s disease
Cell time: How cells control developmental timetables. Rayon T 10 Mar 2023, PMID: 36888707 Science advances
A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK). Sarmad S, Viant MR, Dunn WB, Goodacre R, Wilson ID, Chappell KE, Griffin JL, O'Donnell VB, Naicker B, Lewis MR, Suzuki T, 24 Feb 2023, PMID: 36828894 Nature protocols
The synthetic TRPML1 agonist, ML-SA1, rescues Alzheimer-related alterations of the endosomal-autophagic-lysosomal system. Somogyi A, Kirkham ED, Lloyd-Evans E, Winston J, Allen ND, Mackrill JJ, Anderson KE, Hawkins PT, Gardiner SE, Waller-Evans H, Sims R, Boland B, O'Neill C 24 Feb 2023, PMID: 36825945 Journal of cell science
Targeting pleckstrin-2-Akt signaling reduces proliferation in myeloproliferative neoplasm models. Han X, Mei Y, Mishra RK, Bi H, Jain AD, Schiltz GE, Zhao B, Sukhanova M, Wang P, Grigorescu AA, Weber PC, Piwinski JJ, Prado MA, Paulo JA, Stephens L, Anderson KE, Abrams CS, Yang J, Ji P 31 Jan 2023, PMID: 36719747 The Journal of clinical investigation